HCA Healthcare, Inc. (HCA) HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
Sector: Services-General Medical & Surgical Hospitals, NEC
Industry: Medical - Care Facilities
HCA Healthcare, Inc. NYSE:HCA Healthcare · Medical - Care Facilities
Mkt Cap $106.68B
Div Yield 0.60%
AH After hours $511.98 Prev close $462.86 Close $510.70 Now $511.98 VOL 3.44M $ Vol $1.74B RVOL 2.50x
Mkt Cap $106.68B
VOL 3.44M sh
$ Vol $1.74B
RVOL 2.50×
Div Yield 0.60%
Press Release
HCA Announces Proposed Public Offering of Senior Notes
HCA Healthcare's subsidiary HCA Inc. announced a proposed public offering of senior notes, with terms to be set at pricing.
Net proceeds are earmarked for general corporate purposes, including possible redemption of all $1.2 billion of 4.500% notes due February 2027 and repayment of commercial paper and credit-facility borrowings.
This is routine refinancing via an effective shelf, with Mizuho, Barclays, BofA and Wells Fargo as joint book-runners.
• 2d ago AI analysis › Press Release
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
Healthgrades recognized 102 HCA Healthcare hospitals for specialty care excellence in its 2027 awards, the most of any US health system.
Distinctions include 56 Surgical Care Excellence Awards, 45 Emergency Medicine Excellence Awards, and 52 hospitals among America's 100 Best for Orthopedic Surgery, plus 280 America's Best Specialty distinctions and 617 Specialty Excellence Awards system-wide.
The awards are reputation-based recognitions with no disclosed financial impact, but they support HCA's brand in a competitive patient-acquisition market.
• 6d ago AI analysis › Press Release ● Major ⚠ 4
HCA Healthcare Reports Third Quarter 2026 Results
HCA Healthcare reported Q3 2026 revenue of $19.849 billion, up 3.6% year-over-year, with diluted EPS of $7.27 (+4.5%) and adjusted EPS of $7.22 (+3.7%).
Net income declined 3.9% to $1.579 billion as the company absorbed an estimated $400 million pre-tax hit from a payer mix shift driven by patients losing exchange-based insurance coverage; same facility admissions rose 2.7% and ER visits climbed 5.1%.
Management now expects full-year 2026 results in the upper half of prior guidance ranges (revenue $77.0B-$79.5B, Adjusted EBITDA $15.4B-$16.1B), and returned $2.970 billion via buybacks while declaring a $0.78/share quarterly dividend.
• 8d ago AI analysis › Press Release
HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day
HCA Healthcare will host its eighth annual Crush the Crisis national prescription drug take back day on Saturday, Oct. 24, 2026, with more than 130 collection sites run in partnership with local law enforcement.
Since 2019 the initiative has helped dispose of more than 100,000 pounds of unused or expired medication, with nearly 20,000 pounds collected last year.
The release also highlights HCA's opioid-reduction programs, including Enhanced Surgical Recovery and electronic prescribing of controlled substances. It is a community-relations announcement with no financial impact.
• 14d ago AI analysis › Press Release
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA Healthcare announced it will host its third quarter 2026 earnings call on Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern).
The call will be available via live audio webcast on HCA's investor relations website, with an archive available afterward.
This is a scheduling notice only; no financial results or guidance were included.
• 1mo ago AI analysis › Press Release
HCA Healthcare Presents 2026 Awards of Distinction
HCA Healthcare presented its 2026 Awards of Distinction at a ceremony in Nashville, honoring colleagues, nurses, physicians and volunteers with the Frist Humanitarian Award and Excellence in Nursing Award.
This year introduced the Sammie Mosier Leadership Award, a new category honoring the company's former chief nurse executive, won by Lizette Otero of the TriStar Division.
The release is a corporate culture announcement with no financial or operational implications for investors.
• 1mo ago AI analysis › Press Release ⚠ 1
HCA Healthcare Completes Acquisition of the College of Health Care Professions
HCA Healthcare has completed its previously announced acquisition of The College of Health Care Professions (CHCP), a Texas-based allied-health career college.
CHCP serves more than 8,000 students across 10 Texas campuses and online, offering 20-plus accredited programs and having prepared over 52,000 students for healthcare careers since its 1988 founding.
The deal deepens HCA's education-to-employment pipeline alongside Galen College of Nursing and its 365-plus Graduate Medical Education programs across 87 hospitals, with CHCP chief Eric Bing continuing as Chancellor and CEO.
No purchase price or financial terms were disclosed, and the near-term financial impact on HCA is expected to be modest; the strategic value lies in securing future clinician supply.
• 1mo ago AI analysis › Press Release
MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare
businesswire.com • 1mo ago Press Release
HCA Healthcare, Inc. to Present at September Conferences
HCA Healthcare announced that management is scheduled to present at the Wells Fargo Healthcare Conference on September 9, 2026, and the Jefferies Healthcare Conference on September 15, 2026.
Live audio webcasts and copies of presentation materials will be made available on the Investor Relations section of the company's website.
• 2mo ago AI analysis › Press Release
HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
HCA Healthcare elevated Dr. Michael Schlosser to executive vice president and chief clinical officer, effective September 1, succeeding the retiring Dr. Michael Cuffe.
Simultaneously, the company formed a new Ambulatory Operations Group, appointing Charles Gressle as president to oversee more than 2,700 facilities and clinics.
The restructuring aims to better integrate the company's ambulatory network, with Schlosser continuing to lead digital transformation and Gressle reporting to COO Jon Foster.
• 2mo ago AI analysis › Press Release ● Major ⚠ 3
HCA Healthcare Reports Second Quarter 2026 Results
HCA Healthcare reported Q2 revenue of $20.23 billion, an increase of 8.7% year-over-year, driven by growth in admissions and emergency room visits, while diluted EPS rose 11.6% to $7.62.
Despite the revenue growth, operating cash flow declined to $2.335 billion from $4.210 billion in the prior year, and the company faced a $400 million pre-tax headwind from increased uninsured volume.
Reflecting these pressures, HCA lowered its full-year 2026 guidance for EPS, net income, and Adjusted EBITDA, while maintaining its revenue outlook, and returned significant capital to shareholders through a $2.06 billion share repurchase program and a declared $0.78 per share dividend.
• 3mo ago AI analysis › Press Release
HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
HCA Healthcare announced the date and time for its second quarter 2026 earnings conference call.
The live webcast is scheduled for Friday, July 24, 2026, at 10:00 AM Eastern Time.
An archive of the call will be made available on the company's investor relations website for those unable to attend the live broadcast.
• 3mo ago AI analysis › Press Release ● Major ⚠ 3
HCA Healthcare Previews Second Quarter 2026 Results
HCA Healthcare pre-announced Q2 2026 revenue of $20.23 billion, up 8.8% year-over-year, with Adjusted EBITDA rising to $4.027 billion. Diluted EPS is expected to reach $7.62, compared to $6.83 in the prior year, driven by solid volume growth in admissions and emergency room visits.
However, the company faced a $400 million unfavorable impact from a payer mix shift toward uninsured patients, offset by a $400 million incremental benefit from Medicaid Supplemental Payment Programs. Surgical volumes declined slightly during the quarter.
Due to these dynamics, HCA lowered its full-year 2026 guidance, now projecting revenue of $77.0B-$79.5B and EPS of $28.70-$30.50, down from previous ranges. Capital expenditure guidance remains steady at $5.0B-$5.5B.
• 3mo ago AI analysis › Press Release
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
HCA Healthcare announced the publication of a New England Journal of Medicine study led by Dr. Haydar Frangoul evaluating the use of CRISPR-based therapy exa-cel in children ages 5-11 with sickle cell disease and beta thalassemia.
The study found that all evaluated patients with beta thalassemia achieved transfusion independence for at least 12 months, while all evaluated sickle cell patients remained free of severe vaso-occlusive crises for the same period.
This research underscores the capabilities of HCA's Sarah Cannon Transplant and Cellular Therapy Network, which performs over 1,600 procedures annually, as it expands access to these advanced gene-editing therapies.
• 4mo ago AI analysis › Press Release
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting
businesswire.com • 4mo ago Press Release
Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting
businesswire.com • 4mo ago Press Release ⚠ 2
HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
HCA Healthcare has agreed to acquire The College of Health Care Professions (CHCP), a major allied healthcare training provider in Texas.
The deal aims to strengthen HCA’s talent pipeline by integrating CHCP’s 10 campuses and 8,000+ annual students into HCA’s workforce development ecosystem.
Terms were not disclosed, but the acquisition follows HCA’s prior purchase of Galen College of Nursing and reflects a strategic focus on controlling healthcare education supply.
• 5mo ago AI analysis › Press Release
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
businesswire.com • 5mo ago Press Release
HCA Healthcare, Inc. to Present at May Conference
businesswire.com • 6mo ago Press Release
HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs
HCA Healthcare appointed Cynthia Cifuentes-Finkel as senior vice president of marketing and corporate affairs, effective June 8, 2026.
She succeeds Deb Reiner, who retired after more than 25 years of service, and will report to Mike McAlevey, executive vice president and chief legal and administrative officer.
Cifuentes-Finkel brings over 25 years of experience, most recently serving as regional vice president of communications and strategic partnerships at Kaiser Permanente.
• 6mo ago AI analysis › Press Release
HCA Announces Proposed Public Offering of Senior Notes
HCA Healthcare announced a proposed public offering of senior notes through its subsidiary HCA Inc., though specific terms such as principal amount and interest rate are not yet determined.
Net proceeds from the offering are intended for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program.
The company also stated that proceeds may be used to redeem $1.500 billion of 5.250% notes due June 2026 and $1.000 billion of 5.375% notes due September 2026.
• 6mo ago AI analysis › Press Release ● Major
HCA Healthcare Reports First Quarter 2026 Results
businesswire.com • 6mo ago 
